Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 08 Sept 2026 for 10x Genomics, Inc., €367k. Read the official filing
Filing timeline
BuySaleJohn R. Stuelpnagel
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John R. Stuelpnagel: trading record in brief
John R. Stuelpnagel is a declared insider of 10x Genomics, Inc. (board member), with filings sourced from SEC (Form 4). We count 28 filings; the first trade dates from 3 May 2021 and the latest from 3 September 2026.
No open-market purchase appears, only 22 sales worth €5.7M. Outside the open market, there are 6 share grants. 2026 to date brings no purchases and 5 sales.
The record was last updated on 8 September 2026 with an open-market sale (€333k) in 10x Genomics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John R. Stuelpnagel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
7,012 shares@ US$60.6579Class A Common StockSEC:0001610717-26-000405:0
6,814 shares@ US$62.1082Class A Common StockSEC:0001610717-26-000405:1
6,174 shares@ US$62.6066Class A Common StockSEC:0001610717-26-000405:2
3,000 shares@ US$58.7250.0023% mcap2.7% of flowClass A Common StockSEC:0001610717-26-000358:1
17,000 shares@ US$57.58120.013% mcap15.1% of flowClass A Common StockSEC:0001610717-26-000358:0
8,829 shares0Class A Common StockSEC:0001610717-26-000194:0
15,357 shares0Class A Common StockSEC:0001610717-25-000170:0
8,649 shares0Class A Common StockSEC:0001610717-24-000330:0
1,865 shares0Class A Common StockSEC:0001610717-23-000175:0
10,000 shares@ US$54.88947.6% of flowClass A Common StockSEC:0001610717-23-000099:0
2,120 shares0Class A Common StockSEC:0001567619-22-013121:0
3,218 shares@ US$150.559611.8% of flowClass A Common StockSEC:0001567619-22-000366:0
2,000 shares@ US$150.51087.4% of flowClass A Common StockSEC:0001567619-21-021614:0
800 shares@ US$157.54813.1% of flowClass A Common StockSEC:0001567619-21-020783:0
100 shares@ US$160.330.4% of flowClass A Common StockSEC:0001567619-21-019298:0
4,400 shares@ US$150.513615.8% of flowClass A Common StockSEC:0001567619-21-018503:0
5,000 shares@ US$150.179818.0% of flowClass A Common StockSEC:0001567619-21-018209:0
700 shares@ US$154.45292.5% of flowClass A Common StockSEC:0001209191-21-056956:0
300 shares@ US$175.35831.2% of flowClass A Common StockSEC:0001209191-21-054901:0
300 shares@ US$157.31331.1% of flowClass A Common StockSEC:0001209191-21-052383:0
1,100 shares@ US$178.47594.6% of flowClass A Common StockSEC:0001209191-21-049653:0
500 shares@ US$168.5652.0% of flowClass A Common StockSEC:0001209191-21-047362:0
1,600 shares@ US$189.9437.1% of flowClass A Common StockSEC:0001209191-21-045480:0
100 shares@ US$190.970.4% of flowClass A Common StockSEC:0001209191-21-042115:0
625 shares0Class A Common StockSEC:0001209191-21-040695:0
25 of 28 declarations
